vs
Side-by-side financial comparison of MAGNACHIP SEMICONDUCTOR Corp (MX) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
MAGNACHIP SEMICONDUCTOR Corp is the larger business by last-quarter revenue ($40.6M vs $28.1M, roughly 1.4× ARS Pharmaceuticals, Inc.). MAGNACHIP SEMICONDUCTOR Corp runs the higher net margin — -19.9% vs -147.1%, a 127.2% gap on every dollar of revenue. On growth, MAGNACHIP SEMICONDUCTOR Corp posted the faster year-over-year revenue change (-20.7% vs -67.6%).
Magnachip Semiconductor Corp is a global semiconductor design and manufacturing firm specializing in high-performance analog and mixed-signal solutions. Its core products include display driver ICs, power management ICs and sensors, serving consumer electronics, automotive, industrial and communications markets worldwide.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
MX vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.6M | $28.1M |
| Net Profit | $-8.1M | $-41.3M |
| Gross Margin | 9.3% | — |
| Operating Margin | -26.1% | -147.6% |
| Net Margin | -19.9% | -147.1% |
| Revenue YoY | -20.7% | -67.6% |
| Net Profit YoY | 50.4% | -182.8% |
| EPS (diluted) | $-0.23 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $40.6M | $28.1M | ||
| Q3 25 | $45.9M | $32.5M | ||
| Q2 25 | $47.6M | $15.7M | ||
| Q1 25 | $44.7M | $8.0M | ||
| Q4 24 | $51.2M | $86.6M | ||
| Q3 24 | $55.4M | $2.1M | ||
| Q2 24 | $46.4M | $500.0K | ||
| Q1 24 | $43.4M | $0 |
| Q4 25 | $-8.1M | $-41.3M | ||
| Q3 25 | $-13.1M | $-51.2M | ||
| Q2 25 | $323.0K | $-44.9M | ||
| Q1 25 | $-8.9M | $-33.9M | ||
| Q4 24 | $-16.3M | $49.9M | ||
| Q3 24 | $-9.6M | $-19.1M | ||
| Q2 24 | $-13.0M | $-12.5M | ||
| Q1 24 | $-15.4M | $-10.3M |
| Q4 25 | 9.3% | — | ||
| Q3 25 | 18.6% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.9% | — | ||
| Q4 24 | 21.7% | — | ||
| Q3 24 | 20.8% | — | ||
| Q2 24 | 21.1% | — | ||
| Q1 24 | 14.6% | — |
| Q4 25 | -26.1% | -147.6% | ||
| Q3 25 | -25.1% | -163.7% | ||
| Q2 25 | -15.6% | -302.9% | ||
| Q1 25 | -14.1% | -466.3% | ||
| Q4 24 | -12.5% | 54.5% | ||
| Q3 24 | -8.1% | -1051.6% | ||
| Q2 24 | -12.3% | -3068.0% | ||
| Q1 24 | -21.6% | — |
| Q4 25 | -19.9% | -147.1% | ||
| Q3 25 | -28.5% | -157.4% | ||
| Q2 25 | 0.7% | -285.6% | ||
| Q1 25 | -19.9% | -425.7% | ||
| Q4 24 | -31.8% | 57.7% | ||
| Q3 24 | -17.3% | -925.0% | ||
| Q2 24 | -28.0% | -2503.2% | ||
| Q1 24 | -35.5% | — |
| Q4 25 | $-0.23 | $-0.41 | ||
| Q3 25 | $-0.36 | $-0.52 | ||
| Q2 25 | $0.01 | $-0.46 | ||
| Q1 25 | $-0.24 | $-0.35 | ||
| Q4 24 | $-0.44 | $0.52 | ||
| Q3 24 | $-0.26 | $-0.20 | ||
| Q2 24 | $-0.34 | $-0.13 | ||
| Q1 24 | $-0.40 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.8M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $248.3M | $114.3M |
| Total Assets | $351.5M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.8M | $245.0M | ||
| Q3 25 | $108.0M | $288.2M | ||
| Q2 25 | $113.3M | $240.1M | ||
| Q1 25 | $132.7M | $275.7M | ||
| Q4 24 | $138.6M | $314.0M | ||
| Q3 24 | $151.1M | $204.6M | ||
| Q2 24 | $162.5M | $218.7M | ||
| Q1 24 | $171.6M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $248.3M | $114.3M | ||
| Q3 25 | $255.3M | $147.7M | ||
| Q2 25 | $270.2M | $192.3M | ||
| Q1 25 | $269.2M | $229.0M | ||
| Q4 24 | $276.8M | $256.8M | ||
| Q3 24 | $299.6M | $201.0M | ||
| Q2 24 | $305.8M | $215.2M | ||
| Q1 24 | $321.9M | $223.9M |
| Q4 25 | $351.5M | $327.7M | ||
| Q3 25 | $359.6M | $372.8M | ||
| Q2 25 | $370.5M | $313.5M | ||
| Q1 25 | $373.9M | $327.3M | ||
| Q4 24 | $379.3M | $351.2M | ||
| Q3 24 | $411.4M | $217.6M | ||
| Q2 24 | $412.7M | $222.0M | ||
| Q1 24 | $426.2M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.4M | $-43.5M |
| Free Cash FlowOCF − Capex | $-4.8M | — |
| FCF MarginFCF / Revenue | -11.9% | — |
| Capex IntensityCapex / Revenue | 25.3% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-54.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.4M | $-43.5M | ||
| Q3 25 | $162.0K | $-47.0M | ||
| Q2 25 | $-25.1M | $-39.6M | ||
| Q1 25 | $-4.7M | $-40.7M | ||
| Q4 24 | $11.9M | $42.0M | ||
| Q3 24 | $-12.9M | $-14.5M | ||
| Q2 24 | $-1.1M | $-7.3M | ||
| Q1 24 | $-4.0M | $-6.7M |
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $-7.5M | $-47.2M | ||
| Q2 25 | $-37.0M | $-39.6M | ||
| Q1 25 | $-4.9M | $-40.8M | ||
| Q4 24 | $4.4M | $41.7M | ||
| Q3 24 | $-15.5M | $-14.6M | ||
| Q2 24 | $-2.0M | $-7.3M | ||
| Q1 24 | $-4.6M | $-6.8M |
| Q4 25 | -11.9% | — | ||
| Q3 25 | -16.3% | -145.4% | ||
| Q2 25 | -77.7% | -252.2% | ||
| Q1 25 | -10.9% | -512.1% | ||
| Q4 24 | 8.7% | 48.2% | ||
| Q3 24 | -28.0% | -706.3% | ||
| Q2 24 | -4.3% | -1463.4% | ||
| Q1 24 | -10.7% | — |
| Q4 25 | 25.3% | 0.0% | ||
| Q3 25 | 16.7% | 0.6% | ||
| Q2 25 | 24.9% | 0.3% | ||
| Q1 25 | 0.5% | 1.1% | ||
| Q4 24 | 14.5% | 0.3% | ||
| Q3 24 | 4.7% | 6.8% | ||
| Q2 24 | 1.9% | 7.6% | ||
| Q1 24 | 1.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -77.81× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MX
| Power Analog Solutions | $36.8M | 91% |
| Power Ic | $3.8M | 9% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
